X3 Labs Inc. – Trademark Portfolio

Entity Type: 03

X3 Labs Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include THERA BE, X3 CLEAN, X3 FREEZE, and GERM ATTACK. The owner is based in Unionville, Ontario.

12 Station Lane

Unionville, Ontario L3R 1R3 , CA

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

X3 Labs Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does X3 Labs Inc. have?

X3 Labs Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 1 cancelled.

What trademark classes does X3 Labs Inc. file in?

X3 Labs Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are X3 Labs Inc.'s most well-known trademarks?

X3 Labs Inc.'s registered trademark portfolio includes well-known marks such as THERA BE, X3 CLEAN, X3 FREEZE, and GERM ATTACK. These are among 4 currently registered trademarks in the portfolio.

What is X3 Labs Inc.'s trademark registration success rate?

X3 Labs Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.